Medscape Diabetes & Endocrinology Headlines

On the RECORD: Rosiglitazone Safer Than Previously Thought

Thu, 2 Jul 2009 16:36:17 EDT

: In this video blog, Dr. Anne Peters discusses findings of the RECORD trial, which compared the cardiovascular risks for rosiglitazone with a combination of metformin and sulfonylureas.
Medscape Diabetes & Endocrinology

Bone Mineral Density Monitoring May Not Be Needed Up to 3 Years After Starting Bisphosphonates

Thu, 2 Jul 2009 14:30:04 EDT

A study suggests that monitoring bone mineral density in postmenopausal women in the first 3 years after starting treatment with a potent bisphosphonate is unnecessary and may be misleading.
Medscape Medical News

Insulin Glargine Potentially Associated With Increased Cancer Risk

Wed, 1 Jul 2009 16:52:02 EDT

The increased risk has been seen in 3 of 4 observational studies, but these findings warrant further follow-up studies to confirm an association, according to the FDA.
Medscape Medical News

Nobel-Honored Surgeons: From Discovery of Antibiotics to Organ Transplantation

Wed, 1 Jul 2009 15:20:30 EDT

Since the Nobel prize was first presented 100 years ago, only 10 surgeons have been honored. Their contributions range from the discovery of antibiotics to the first organ transplantation. Dr. Albert Lowenfels surveys their lives and accomplishments.
Medscape General Surgery

Enalapril, Losartan May Have Retinal, but Not Renal, Benefits in Type 1 Diabetes

Wed, 1 Jul 2009 12:38:52 EDT

In a controlled trial, early blockade of the renin-angiotensin system did not slow the progression of nephropathy but slowed the progression of retinopathy in patients with type 1 diabetes.
Medscape Medical News

Alogliptin Delayed; Cancer Concerns With Insulin Glargine

Tue, 30 Jun 2009 17:29:04 EDT

The makers of alogliptin say it will be two years before they have the cardiovascular data needed by the FDA, while the EASD raises concerns over a possible cancer risk with insulin glargine.
Heartwire

ASMBS 2009: Socioeconomic Factors Figure Prominently in Access to Bariatric Surgery

Tue, 30 Jun 2009 13:18:01 EDT

Focused public health efforts are needed to reduce significant race-, income-, education-, and insurance-related disparities and to equalize and expand access to bariatric surgery.
Medscape Medical News

Sanofi's Lantus Linked to Cancer: What Is Known?

Tue, 30 Jun 2009 11:47:27 EDT

Sanofi-Aventis's diabetes drug Lantus may increase the risk of cancer, according to new but inconclusive studies from experts around Europe.
Reuters Health Information

Risk for Pancreatic Cancer Increased by Early-Adulthood Obesity and Dietary Fat of Animal Origin

Tue, 30 Jun 2009 08:49:32 EDT

Two new studies provide details on how obesity and animal fats increase the risk for pancreatic cancer, and may offer new insight into pancreatic tumorigenesis.
Medscape Medical News

Structured, Systematic Care Improves Outcome in Diabetics

Tue, 30 Jun 2009 11:56:40 EDT

A structured approach to management of patients with type 2 diabetes can lead to better outcomes, Chinese researchers report in the June issue of Diabetes Care.
Reuters Health Information

Common UCP2 Polymorphism Linked to Worse Survival After MI

Tue, 30 Jun 2009 11:56:40 EDT

A common polymorphism in the uncoupling protein 2 (UCP2) gene is associated with worse survival in diabetic patients after myocardial infarction (MI), according to a report in the June 15th Cardiovascular Diabetology.
Reuters Health Information

ASMBS 2009: Elderly Obese Patients Benefit From Weight Loss Surgery

Mon, 29 Jun 2009 14:28:31 EDT

Complications and outcomes of gastric surgery are no worse for patients older than 65 years than for younger patients.
Medscape Medical News

ASMBS 2009: Gastric Banding Achieves Sustained Weight Loss, Improvement of Diabetes

Mon, 29 Jun 2009 11:20:44 EDT

Laparoscopic gastric banding results in a combined improvement/resolution rate of 80% in morbidly obese patients with type 2 diabetes.
Medscape Medical News

Atrial Fibrillation Increases Risk of Death in Diabetics

Mon, 29 Jun 2009 11:56:06 EDT

Atrial fibrillation is a strong independent predictor of overall mortality and cardiovascular events in diabetic patients, according to findings published in the May issue of the European Heart Journal.
Reuters Health Information

REM Sleep-Related OSA Associated With Type 2 Diabetes: Study

Mon, 29 Jun 2009 11:56:05 EDT

There is a statistically significant association between type 2 diabetes and obstructive sleep apnea (OSA) during REM sleep, results of a study indicate.
Reuters Health Information

Insulin Resistance Independently Predicts the Progression of Coronary Artery Calcification

Mon, 29 Jun 2009 16:31:56 EDT

Insulin resistance, in addition to the traditional cardiac risk factors, independently predicts progression of CAC in a community-based population without clinical CAD.
American Heart Journal

Health-Care-Associated Infections: The Legislative Perspective and the Pharmacist's Role

Mon, 29 Jun 2009 22:09:05 EDT

Pharmacists are integral to the development of proactive methods to help prevent health-care-associated infections.
American Journal of Health-System Pharmacy

The Association of Periodontal Disease, Diabetes, and Cardiovascular Disease

Tue, 30 Jun 2009 17:02:15 EDT

Periodontal disease in emerging as an important risk factor for cardiovascular disease and diabetes.
The British Journal of Diabetes and Vascular Disease